Literature DB >> 15717659

Clinical manifestations and hormonal profile of two women with Cushing's disease and mild deficiency of 21-hydroxylase.

M Boronat1, A Carrillo, A Ojeda, J Estrada, B Ezquieta, F Marín, F J Nóvoa.   

Abstract

The development of Cushing's disease among patients with deficiency of 21-hydroxylase has not been observed to date. The clinical manifestations and the hormonal profile of this exceptional association are herein described through the study of two cases. The first one was a 39-yr-old woman who had undergone non-curative transsphenoidal surgery for a pituitary-dependent Cushing's syndrome 12 yr before. She showed hypertension, central obesity, severe hirsutism, alopecia and hyperpigmentation. Urinary excretion of cortisol was normal, but ACTH levels were very high and hormonal dynamic studies (cortisol circadian rhythm, insulin-induced hypoglycemia and dexamethasone suppression tests) revealed the qualitative disturbances that characterize Cushing's disease. Serum concentrations of androstenedione, free testosterone and 17-hydroxyprogesterone were clearly increased. Reexamination of the tissue samples from previous surgery confirmed the presence of an ACTH-producing pituitary adenoma. CYP21 gene analysis found the splicing 655G mutation at intron 2 and the V281L mutation at exon 7. The second case was a 21-yr-old woman who was diagnosed with pituitary ACTH-dependent Cushing's syndrome according to unequivocal clinical and laboratory findings. However, hirsutism was particularly severe and both serum androgens and 17-hydroxyprogesterone were elevated. The patient was heterozygote for a large conversion of CYP21 gene. In these cases, the clinical and biochemical expression of Cushing's syndrome was determined by the different severity of 21-hydroxylase deficiency and the subsequent residual ability of adrenal cortex to synthesize cortisol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15717659     DOI: 10.1007/BF03347484

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease.

Authors:  J Estrada; J García-Uría; C Lamas; J Alfaro; T Lucas; S Diez; L Salto; B Barceló
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

2.  Molecular cloning of steroid 21-hydroxylase.

Authors:  P C White; M I New; B Dupont
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

3.  Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.

Authors:  J López; B Barceló; T Lucas; F Salame; C Alameda; M Boronat; L Salto; J Estrada
Journal:  Clin Endocrinol (Oxf)       Date:  1996-08       Impact factor: 3.478

4.  The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.

Authors:  J Estrada; M Boronat; M Mielgo; R Magallón; I Millan; S Díez; T Lucas; B Barceló
Journal:  N Engl J Med       Date:  1997-01-16       Impact factor: 91.245

5.  How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?

Authors:  G A Kaltsas; M Korbonits; A M Isidori; J A Webb; P J Trainer; J P Monson; G M Besser; A B Grossman
Journal:  Clin Endocrinol (Oxf)       Date:  2000-10       Impact factor: 3.478

6.  Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.

Authors:  L Barbetta; C Dall'Asta; T Re; P Colombo; P Travaglini; B Ambrosi
Journal:  Horm Metab Res       Date:  2001-10       Impact factor: 2.936

7.  Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.

Authors:  H Frisch; K Parth; E Schober; W Swoboda
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

8.  Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.

Authors:  S Jaresch; E Kornely; H K Kley; R Schlaghecke
Journal:  J Clin Endocrinol Metab       Date:  1992-03       Impact factor: 5.958

9.  Computed tomography in untreated adults with virilizing congenital adrenal cortical hyperplasia.

Authors:  T H Falke; A P van Seters; A Schaberg; A J Moolenaar
Journal:  Clin Radiol       Date:  1986-03       Impact factor: 2.350

10.  Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome.

Authors:  L Zarrilli; A Colao; B Merola; G La Tessa; R Spaziante; F S Tripodi; A Di Sarno; L A Marzano; G Lombardi
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

View more
  3 in total

1.  Gene mutations in Cushing's disease.

Authors:  Qi Xiong; Wei Ge
Journal:  Biomed Rep       Date:  2016-07-29

Review 2.  Its written all over your face: The molecular and physiological consequences of aging skin.

Authors:  W E Lowry
Journal:  Mech Ageing Dev       Date:  2020-07-15       Impact factor: 5.432

3.  A case of congenital adrenal hyperplasia mimicking Cushing's syndrome.

Authors:  Hye Jeong Kim; Mira Kang; Jae Hyeon Kim; Sun Wook Kim; Jae Hoon Chung; Yong-Ki Min; Moon-Kyu Lee; Kwang-Won Kim; Myung-Shik Lee
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.